Biote Corp. Class A Share Price
NASDAQ: BTMD | Micro CapBiote Corp. Class A Stock Performance
Open $1.64 | Prev. Close $1.63 | Circuit Range N/A |
Day Range $1.57 - $1.69 | Year Range $1.27 - $3.61 | Volume 6,086 |
Average Traded $1.61 |
Biote Corp. Class A Share Price Today
As of 29 August 2026, Biote Corp. Class A's share price is $1.58. The stock opened at $1.64, compared to its previous close of $1.63. During today's trading session, Biote Corp. Class A's share price traded between $1.57 and $1.69, with an average price of $1.63. Over the past 52 weeks, the stock has recorded a high of $3.61 and a low of $1.27. In terms of performance, Biote Corp. Class A's share price has declined by 25.82% over the last six months and is down 54.07% on a year-on-year basis.
Biote Corp. Class A Share Price Chart
Biote Corp. Class A Stock Fundamentals & Key Indicators
Market Cap $49.43M | PE Ratio (TTM) 1.84 | Dividend Yield 3.80% |
EPS (TTM) $0.86 | Revenue (TTM) $192.22M | Return On Equity (TTM) -53.98% |
Profit Margin 16.44% | Debt to Equity -0.77 | Quarterly Earnings Growth YoY -23.49% |
Biote Corp. Class A Quarterly Profit & Loss
All figures in USD
Biote Corp. Class A Annual Profit & Loss
All figures in USD
About Biote Corp. Class A
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.
Biote Corp. Class A Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $2.28 | $1.63 | -27.23% |
Jul 2026 | $1.99 | $2.24 | +19.47% |
Jun 2026 | $2.00 | $1.88 | -7.18% |
May 2026 | $2.25 | $2.02 | -8.60% |
Apr 2026 | $1.35 | $2.21 | +64.93% |
Mar 2026 | $2.08 | $1.34 | -37.09% |
Feb 2026 | $2.07 | $2.13 | +2.65% |
Jan 2026 | $2.54 | $2.08 | -19.88% |
Dec 2025 | $2.63 | $2.59 | -3.36% |
Nov 2025 | $2.87 | $2.68 | -6.62% |
Oct 2025 | $3.00 | $2.87 | -4.65% |
Sep 2025 | $3.40 | $3.01 | -12.50% |